ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important November 23 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm – TEVA
November 10, 2020 15:10 ET
|
The Rosen Law Firm PA
NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE: TEVA)...
Global Neurodegenerative Disorder Therapeutics Market - Improvement in the healthcare infrastructure is likely to create new opportunity for the market
August 13, 2020 10:34 ET
|
PMI
Covina, CA, Aug. 13, 2020 (GLOBE NEWSWIRE) -- The report "Global Neurodegenerative Disorder Therapeutics Market, By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis,...
Teva May have a Problem Resulting from Opioid Epidemic: Barbuto & Johansson, P.A. Updates Investors of Class Action Lawsuit Against Teva Pharmaceutical
July 23, 2019 12:04 ET
|
Barbuto & Johansson
WELLINGTON, Fla., July 23, 2019 (GLOBE NEWSWIRE) -- Barbuto & Johansson, P.A. (“BARJO”) and Of Counsel, Neil Rothstein, Esq. (with over 30 years of Securities Class Action Experience, including...
Barbuto & Johansson, P.A. reminds TEVA, EQT, FRED and RBGLY Shareholders of Class Action Deadlines
July 18, 2019 11:04 ET
|
Barbuto & Johansson
WELLINGTON, Fla., July 18, 2019 (GLOBE NEWSWIRE) -- Barbuto & Johansson, P.A. (“BARJO”) and Of Counsel, Neil Rothstein, Esq. (with over 30 years of Securities Class Action Experience, including...
Barbuto & Johansson, P.A. Informs Investors of the Pending Class Action Lawsuit Against Teva Pharmaceutical and Encourages Investors to Contact the Firm
July 01, 2019 03:00 ET
|
Barbuto & Johansson
WELLINGTON, Fla., July 01, 2019 (GLOBE NEWSWIRE) -- Barbuto & Johansson, P.A. (“BARJO”) and Of Counsel, Neil Rothstein, Esq. (with over 30 years of Securities Class Action Experience, including...
B. Braun’s OnGuard® CSTD Qualifies as an Effective Barrier for Vapor Release Based on the NIOSH Draft Universal Protocol
January 08, 2019 12:56 ET
|
B. Braun Medical Inc.--US
BETHLEHEM, Pa., Jan. 08, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. announced today that OnGuard® Closed System Transfer Device (CSTD) demonstrated effective barrier performance under the...
U.S. Intrauterine Devices Market worth over $2.0 bn by 2024: Global Market Insights, Inc.
September 19, 2018 07:00 ET
|
Global Market Insights, Inc
Sellbyville, Delaware, Sept. 19, 2018 (GLOBE NEWSWIRE) -- The U.S. Intrauterine Device Market will surpass USD 2.0 billion by 2024; according to a new research study published by Global Market...
TEVA REMINDER: Investors With Losses In Excess of $1,000,000 Are Reminded to Contact the Rosen Law Firm Regarding the Important January 5 Deadline in Class Action Filed by Firm- TEVA
December 27, 2016 09:00 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 27, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the American Depositary Shares (“ADSs”) of Teva Pharmaceutical Industries Limited...
Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA
December 12, 2016 18:23 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 12, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the American Depositary...
Biotech/Pharma Stocks Battle for the Sexual Health Market: BioSante Pharmaceuticals, (NASDAQ: BPAX), Pfizer, Teva Pharmaceutical, Watson
June 27, 2011 13:04 ET
|
InvestorIdeas.com
POINT ROBERTS, WA--(Marketwire - Jun 27, 2011) - Investorideas.com, an investor research portal covering leading sectors including biotech and pharma stocks, features a sector snapshot of...